BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Lymphoma AND NF1, NFNS, 4763, ENSG00000196712, P21359 AND Diagnosis
22 results:

  • 1. Neurocutaneous Syndromes, Perinatal Factors, and the Risk of Childhood Cancer in Sweden.
    Kampitsi CE; Nordgren A; Mogensen H; Pontén E; Feychting M; Tettamanti G
    JAMA Netw Open; 2023 Jul; 6(7):e2325482. PubMed ID: 37490289
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. lymphomas in patients with neurofibromatosis type 1 (nf1): another malignancy in the nf1 syndrome?
    Fareez F; Wang BH; Brain I; Lu JQ
    Pathology; 2023 Apr; 55(3):302-314. PubMed ID: 36774237
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Genetic correlation of crizotinib efficacy and resistance in ALK- rearranged non-small-cell lung cancer.
    Liu C; Liu C; Liao J; Yin JC; Wu X; Zhao X; Sun S; Wang H; Hu Z; Zhang Y; Yu H; Shao Y; Wang J
    Lung Cancer; 2022 Sep; 171():18-25. PubMed ID: 35870258
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Neurofibromatosis from Head to Toe: What the Radiologist Needs to Know.
    Wang MX; Dillman JR; Guccione J; Habiba A; Maher M; Kamel S; Panse PM; Jensen CT; Elsayes KM
    Radiographics; 2022; 42(4):1123-1144. PubMed ID: 35749292
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Retrospective and integrative analyses of molecular characteristics and their specific imaging parameters in pediatric grade 1 gliomas.
    Coutant M; Lhermitte B; Guérin E; Chammas A; Reita D; Sebastia C; Douzal V; Gabor F; Salmon A; Chenard MP; Todeschi J; Coca A; Heng MA; Vincent F; Entz-Werlé N
    Pediatr Blood Cancer; 2022 Aug; 69(8):e29575. PubMed ID: 35373885
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Frequency of Pathogenic Germline Variants in Cancer-Susceptibility Genes in the Childhood Cancer Survivor Study.
    Kim J; Gianferante M; Karyadi DM; Hartley SW; Frone MN; Luo W; Robison LL; Armstrong GT; Bhatia S; Dean M; Yeager M; Zhu B; Song L; Sampson JN; Yasui Y; Leisenring WM; Brodie SA; de Andrade KC; Fortes FP; Goldstein AM; Khincha PP; Machiela MJ; McMaster ML; Nickerson ML; Oba L; Pemov A; Pinheiro M; Rotunno M; Santiago K; Wegman-Ostrosky T; Diver WR; Teras L; Freedman ND; Hicks BD; Zhu B; Wang M; Jones K; Hutchinson AA; Dagnall C; Savage SA; Tucker MA; Chanock SJ; Morton LM; Stewart DR; Mirabello L
    JNCI Cancer Spectr; 2021 Apr; 5(2):. PubMed ID: 34308104
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Coincidental Expression of Classic Hodgkin lymphoma and Neurofibromatosis Type I and Literature Review.
    Cabrera TB; Wang W; Yedururi S; Slopis JM; Steiner RE; Rytting ME; Cuglievan B
    J Pediatr Hematol Oncol; 2021 May; 43(4):e535-e538. PubMed ID: 32366782
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Genomic Profiling of Childhood Tumor Patient-Derived Xenograft Models to Enable Rational Clinical Trial Design.
    Rokita JL; Rathi KS; Cardenas MF; Upton KA; Jayaseelan J; Cross KL; Pfeil J; Egolf LE; Way GP; Farrel A; Kendsersky NM; Patel K; Gaonkar KS; Modi A; Berko ER; Lopez G; Vaksman Z; Mayoh C; Nance J; McCoy K; Haber M; Evans K; McCalmont H; Bendak K; Böhm JW; Marshall GM; Tyrrell V; Kalletla K; Braun FK; Qi L; Du Y; Zhang H; Lindsay HB; Zhao S; Shu J; Baxter P; Morton C; Kurmashev D; Zheng S; Chen Y; Bowen J; Bryan AC; Leraas KM; Coppens SE; Doddapaneni H; Momin Z; Zhang W; Sacks GI; Hart LS; Krytska K; Mosse YP; Gatto GJ; Sanchez Y; Greene CS; Diskin SJ; Vaske OM; Haussler D; Gastier-Foster JM; Kolb EA; Gorlick R; Li XN; Reynolds CP; Kurmasheva RT; Houghton PJ; Smith MA; Lock RB; Raman P; Wheeler DA; Maris JM
    Cell Rep; 2019 Nov; 29(6):1675-1689.e9. PubMed ID: 31693904
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Multiple primary malignancies associated with a germline SMARCB1 pathogenic variant.
    Eelloo JA; Smith MJ; Bowers NL; Ealing J; Hulse P; Wylie JP; Shenjere P; Clarke NW; Soh C; Whitehouse RW; Jones M; Duff C; Freemont A; Gareth Evans D
    Fam Cancer; 2019 Oct; 18(4):445-449. PubMed ID: 31240424
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. WHO 2016 classification: changes and advancements in the diagnosis of miscellaneous primary CNS tumours.
    Sahm F; Reuss DE; Giannini C
    Neuropathol Appl Neurobiol; 2018 Feb; 44(2):163-171. PubMed ID: 28295484
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Humoral immunity to tetanus, measles and rubella in children with acute lymphoblastic leukemia after chemotherapy.
    Onorateli M; Botana C; Peralta L; Rebollo M; Ruvinsky S; Guitter M; Felice MS; Posadas M; Evangelista S; Villar MV; Golluscio M; Molina A; Fraquelli L
    Arch Argent Pediatr; 2016 Dec; 114(6):549-552. PubMed ID: 27869413
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Neurofibromatosis type 1 and malignancy in childhood.
    Varan A; Şen H; Aydın B; Yalçın B; Kutluk T; Akyüz C
    Clin Genet; 2016 Mar; 89(3):341-5. PubMed ID: 26073032
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Subcutaneous panniculitis-like T-cell lymphoma in type 1 neurofibromatosis: a case report.
    Reich A; Butrym A; Mazur G; Tubek S; Wąsik G; Brzezicha B; Woźniak Z
    Acta Dermatovenerol Croat; 2014; 22(2):145-9. PubMed ID: 25102802
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. SPRED1, a RAS MAPK pathway inhibitor that causes Legius syndrome, is a tumour suppressor downregulated in paediatric acute myeloblastic leukaemia.
    Pasmant E; Gilbert-Dussardier B; Petit A; de Laval B; Luscan A; Gruber A; Lapillonne H; Deswarte C; Goussard P; Laurendeau I; Uzan B; Pflumio F; Brizard F; Vabres P; Naguibvena I; Fasola S; Millot F; Porteu F; Vidaud D; Landman-Parker J; Ballerini P
    Oncogene; 2015 Jan; 34(5):631-8. PubMed ID: 24469042
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Central nervous system lymphoma occurring in a patient with neurofibromatosis type 1 (von Recklinghausen disease).
    Eoli M; Bianchessi D; Di Stefano AL; Prodi E; Anghileri E; Finocchiaro G
    Neurol Sci; 2012 Dec; 33(6):1429-33. PubMed ID: 22294052
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Rescue of genomic information in adult acute lymphoblastic leukaemia (ALL) with normal/failed cytogenetics: a GIMEMA centralized biological study.
    Matteucci C; Barba G; Varasano E; Vitale A; Mancini M; Testoni N; Cuneo A; Rege-Cambrin G; Elia L; La Starza R; Pierini V; Brandimarte L; Vignetti M; Foà R; Mecucci C;
    Br J Haematol; 2010 Apr; 149(1):70-8. PubMed ID: 20067559
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Assessment of sacrum scalloping in neurofibromatosis type 1 caused by a giant cell lesion of the sacrum.
    Lee HC; Cho DY
    Surg Neurol; 2006 Feb; 65(2):194-8; discussion 198. PubMed ID: 16427426
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Neurofibromatosis von Recklinghausen type I phenotype and early onset of cancers in siblings compound heterozygous for mutations in MSH6.
    Ostergaard JR; Sunde L; Okkels H
    Am J Med Genet A; 2005 Dec; 139A(2):96-105; discussion 96. PubMed ID: 16283678
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Childhood and adolescent lymphoid and myeloid leukemia.
    Pui CH; Schrappe M; Ribeiro RC; Niemeyer CM
    Hematology Am Soc Hematol Educ Program; 2004; ():118-45. PubMed ID: 15561680
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Neurofibromatosis type 1 associated with central nervous system lymphoma.
    Zein G; Yu E; Tawansy K; Berta A; Foster CS
    Ophthalmic Genet; 2004 Mar; 25(1):49-51. PubMed ID: 15255115
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.